Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [912]
News [3696]
Articles [22]
Editorials [1]
Conferences [136]
elearning [0]
European Commission approves cabozantinib for the first-line treatment of adults with intermediate/poor-risk advanced renal cell carcinoma
European Commission approves cabozantinib for the first-line treatment of adults with intermediate/poor-risk...
Erectile dysfunction drugs and flu vaccine may fight cancer after surgery
Erectile dysfunction drugs and flu vaccine may fight cancer after surgery
ASCO 2018: Shorter trastuzumab treatment for HER2 positive breast cancer can be as effective, with fewer cardiac side effects
ASCO 2018: Shorter trastuzumab treatment for HER2 positive breast cancer can be as effective, with fewer cardiac...
Cellular valve structure opens up potential novel therapies
Cellular valve structure opens up potential novel therapies
Cell type switch helps colon cancer evade treatment, study suggests
Cell type switch helps colon cancer evade treatment, study suggests
Blocking two enzymes could make cancer cells vulnerable
Blocking two enzymes could make cancer cells vulnerable
Researchers uncover up to 100 potential drug targets for cancer
Researchers uncover up to 100 potential drug targets for cancer
Unlocking cancer's secrets using the 'social networks' of cells
Unlocking cancer's secrets using the 'social networks' of cells
Scientists identify cause of resistance to breakthrough breast and ovarian cancer drug
Scientists identify cause of resistance to breakthrough breast and ovarian cancer drug
Olaparib approved in EU for platinum-sensitive relapsed ovarian cancer
Olaparib approved in EU for platinum-sensitive relapsed ovarian cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation